IA
HRTX icon

IFP Advisors’s Heron Therapeutics HRTX Stock Holding History

IFP Advisors’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51 Sell
120
-216
-64% -$173 ﹤0.01% 5020
2026
Q1 		$269 Sell
336
-25
-7% -$29 ﹤0.01% 4561
2025
Q4 		$469 Sell
361
-155
-30% -$191 ﹤0.01% 4298
2025
Q3 		$650 Buy
516
+482
+1,418% +$764 ﹤0.01% 4097
2025
Q2 		$70 Buy
+34
New +$69 ﹤0.01% 4776
2025
Q1 		– Sell
-35
Closed -$54 – 4465
2024
Q4 		$54 Buy
+35
New +$57 ﹤0.01% 4236
2023
Q4 		– Sell
-271
Closed -$279 – 3188
2023
Q3 		$279 Buy
+271
New +$386 ﹤0.01% 3164
2021
Q2 		– Sell
-200
Closed -$3.18K – 3133
2021
Q1 		$3K Buy
200
+158
+376% +$2.82K ﹤0.01% 2564
2020
Q4 		$1K Buy
+42
New +$730 ﹤0.01% 2763
2019
Q1 		– Sell
-14
Closed – – 2812
2018
Q4 		$0 Sell
14
-225
-94% -$6.19K ﹤0.01% 3685
2018
Q3 		$8K Buy
239
+25
+12% +$931 ﹤0.01% 2971
2018
Q2 		$8K Buy
+214
New +$6.81K ﹤0.01% 3031
2017
Q1 		– Sell
-1
Closed – – 4051
2016
Q4 		$0 Hold
1
– – ﹤0.01% 4045
2016
Q3 		$0 Sell
1
-11
-92% -$204 ﹤0.01% 3953
2016
Q2 		$0 Buy
+12
New +$234 ﹤0.01% 3923
2016
Q1 		– Sell
-11
Closed – – 2831
2015
Q4 		$0 Buy
+11
New +$294 ﹤0.01% 3755

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

IFP Advisors's HRTX Position: Q2 2026 in Review

IFP Advisors reduced its Heron Therapeutics (HRTX) stake by 64% in Q2 2026, selling an estimated $173 and leaving 120 shares worth $51. The position accounts for ﹤0.01% of the portfolio, ranked #5020.

IFP Advisors first reported a position in HRTX in Q4 2015 and has held it in 16 quarters since. The position peaked at $8K in Q3 2018. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • IFP Advisors held 120 shares of Heron Therapeutics worth $51 as of Q2 2026.
  • IFP Advisors sold 216 Heron Therapeutics shares in Q2 2026, an estimated $173.
  • Heron Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #5020 holding.
  • IFP Advisors first reported a position in Heron Therapeutics in Q4 2015 and has held it in 16 quarters since.
  • IFP Advisors's Heron Therapeutics position peaked at $8K in Q3 2018.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.